Single User License
INR 170050
Site License
INR 340100
Corporate User License
INR 510150

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Ocular Hypertension Global Clinical Trials Review, H1

Ocular Hypertension Global Clinical Trials Review, H1


  Request for Sample Report

Executive Summary

Ocular Hypertension Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Ocular Hypertension Global Clinical Trials Review, H1, 2015" provides an overview of Ocular Hypertension clinical trials scenario. This report provides top line data relating to the clinical trials on Ocular Hypertension. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Ocular Hypertension 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Five Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Ocular Hypertension to Ophthalmology Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Ocular Hypertension to Ophthalmology Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Ocular Hypertension 25

Subjects Recruited Over a Period of Time 28

Clinical Trials by Sponsor Type 29

Prominent Sponsors 30

Top Companies Participating in Ocular Hypertension Therapeutics Clinical Trials 31

Prominent Drugs 32

Latest Clinical Trials News on Ocular Hypertension 33

May 11, 2015: Promising preclinical data on NCX 667 for glaucoma presented at ARVO by Nicox 33

May 11, 2015: Promising preclinical data on NCX 470 for glaucoma presented at ARVO by Nicox 33

Apr 23, 2015: Aerie Pharmaceuticals Reports Initial Rhopressa Phase 3 Efficacy Results 33

Mar 24, 2015: Aerie Pharmaceuticals Completes Enrollment in Second Phase 3 Registration Trial of Rhopressa, Novel Triple-Action Product to Lower Intraocular Pressure in Patients with Glaucoma 34

Clinical Trial Profiles 36

Clinical Trial Overview of Top Companies 36

Novartis AG 36

Clinical Trial Overview of Novartis AG 36

Actavis plc 43

Clinical Trial Overview of Actavis plc 43

Pfizer Inc. 49

Clinical Trial Overview of Pfizer Inc. 49

Santen Pharmaceutical Co., Ltd. 52

Clinical Trial Overview of Santen Pharmaceutical Co., Ltd. 52

Aerie Pharmaceuticals, Inc. 55

Clinical Trial Overview of Aerie Pharmaceuticals, Inc. 55

Valeant Pharmaceuticals International, Inc. 57

Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 57

Merck & Co., Inc. 59

Clinical Trial Overview of Merck & Co., Inc. 59

QLT Inc. 60

Clinical Trial Overview of QLT Inc. 60

Mati Therapeutics Inc. 61

Clinical Trial Overview of Mati Therapeutics Inc. 61

Kowa Company, Ltd. 62

Clinical Trial Overview of Kowa Company, Ltd. 62

Clinical Trial Overview of Top Institutes / Government 63

Medical University of Vienna 63

Clinical Trial Overview of Medical University of Vienna 63

Aristotle University Of Thessaloniki 64

Clinical Trial Overview of Aristotle University Of Thessaloniki 64

University of Colorado Denver 65

Clinical Trial Overview of University of Colorado Denver 65

University of Sao Paulo 66

Clinical Trial Overview of University of Sao Paulo 66

Association for Research in Supporting System of Chronic Diseases 67

Clinical Trial Overview of Association for Research in Supporting System of Chronic Diseases 67

Department of Health, South Africa 68

Clinical Trial Overview of Department of Health, South Africa 68

IRCCS Fondazione G.B. Bietti per lo Studio e la Ricerca in Oftalmologia ONLUS 69

Clinical Trial Overview of IRCCS Fondazione G.B. Bietti per lo Studio e la Ricerca in Oftalmologia ONLUS 69

University Health Network 70

Clinical Trial Overview of University Health Network 70

University of Nebraska 71

Clinical Trial Overview of University of Nebraska 71

University of Parma 72

Clinical Trial Overview of University of Parma 72

Five Key Clinical Profiles 73

Appendix 100

Abbreviations 100

Definitions 100

Research Methodology 101

Secondary Research 101

About GlobalData 102

Contact Us 102

Disclaimer 102

Source 102

List of Figures

Ocular Hypertension Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Ocular Hypertension Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Ocular Hypertension Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Ocular Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Ocular Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Ocular Hypertension Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Ocular Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13

Ocular Hypertension Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14

Proportion of Ocular Hypertension to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15

Ocular Hypertension Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Ocular Hypertension Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Ocular Hypertension to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18

Ocular Hypertension Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Ocular Hypertension Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Ocular Hypertension Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Ocular Hypertension Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Ocular Hypertension Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Ocular Hypertension Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Ocular Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Ocular Hypertension Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29

Ocular Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Ocular Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Ocular Hypertension Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

GlobalData Methodology 101

List of Tables

Ocular Hypertension Therapeutics, Global, Clinical Trials by Region, 2015* 7

Ocular Hypertension Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Ocular Hypertension Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Ocular Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Ocular Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Ocular Hypertension Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Ocular Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13

Ocular Hypertension Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14

Proportion of Ocular Hypertension to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15

Ocular Hypertension Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Ocular Hypertension Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Ocular Hypertension to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18

Ocular Hypertension Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Ocular Hypertension Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Ocular Hypertension Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Ocular Hypertension Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Ocular Hypertension Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Ocular Hypertension Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Ocular Hypertension Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Ocular Hypertension Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26

Ocular Hypertension Therapeutics, Global, Terminated Clinical Trials, 2015* 27

Ocular Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Ocular Hypertension Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29

Ocular Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Ocular Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Ocular Hypertension Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 36

Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2015* 43

Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 49

Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Santen Pharmaceutical Co., Ltd., 2015* 52

Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Aerie Pharmaceuticals, Inc., 2015* 55

Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2015* 57

Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015* 59

Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by QLT Inc., 2015* 60

Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Mati Therapeutics Inc., 2015* 61

Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Kowa Company, Ltd., 2015* 62

Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015* 63

Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Aristotle University Of Thessaloniki, 2015* 64

Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado Denver, 2015* 65

Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2015* 66

Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Association for Research in Supporting System of Chronic Diseases, 2015* 67

Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, South Africa, 2015* 68

Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by IRCCS Fondazione G.B. Bietti per lo Studio e la Ricerca in Oftalmologia ONLUS, 2015* 69

Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2015* 70

Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Nebraska, 2015* 71

Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Parma, 2015* 72

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Novartis AG

Actavis plc

Pfizer Inc.

Santen Pharmaceutical Co., Ltd.

Aerie Pharmaceuticals, Inc.

Valeant Pharmaceuticals International, Inc.

Merck & Co., Inc.

QLT Inc.

Mati Therapeutics Inc.

Kowa Company, Ltd.

Ocular Hypertension Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Ocular Hypertension, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com